Bevacizumab for retinopathy of prematurity and neurodevelopment
- PMID: 36623638
- DOI: 10.1016/j.jaapos.2023.01.002
Bevacizumab for retinopathy of prematurity and neurodevelopment
Comment in
-
Bevacizumab for retinopathy of prematurity and neurodevelopment.J AAPOS. 2024 Feb;28(1):103786. doi: 10.1016/j.jaapos.2023.08.018. Epub 2023 Nov 4. J AAPOS. 2024. PMID: 37926389 No abstract available.
Similar articles
-
Bevacizumab for retinopathy of prematurity and neurodevelopment.J AAPOS. 2024 Feb;28(1):103786. doi: 10.1016/j.jaapos.2023.08.018. Epub 2023 Nov 4. J AAPOS. 2024. PMID: 37926389 No abstract available.
-
Intravitreal bevacizumab injection for retinopathy of prematurity and pulmonary hypertension.J Perinatol. 2023 Feb;43(2):236-237. doi: 10.1038/s41372-022-01489-0. Epub 2022 Aug 15. J Perinatol. 2023. PMID: 35970854 No abstract available.
-
[Neurodevelopment in patients with retinopathy of prematurity treated with intravitreal bevacizumab. Case series].Cir Cir. 2017 Nov-Dec;85(6):478-484. doi: 10.1016/j.circir.2016.10.031. Epub 2017 Jan 19. Cir Cir. 2017. PMID: 28110900 Spanish.
-
Intravitreal bevacizumab for retinopathy of prematurity: Considerations for informed consent.Can J Ophthalmol. 2015 Dec;50(6):409-12. doi: 10.1016/j.jcjo.2015.10.004. Can J Ophthalmol. 2015. PMID: 26651298 Review. No abstract available.
-
Retinopathy of Prematurity: Evolving Treatment With Anti-Vascular Endothelial Growth Factor.Am J Ophthalmol. 2020 Oct;218:208-213. doi: 10.1016/j.ajo.2020.05.025. Epub 2020 May 23. Am J Ophthalmol. 2020. PMID: 32450064 Free PMC article. Review.
Cited by
-
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): five-year outcomes of a randomised trial.EClinicalMedicine. 2024 Apr 11;71:102567. doi: 10.1016/j.eclinm.2024.102567. eCollection 2024 May. EClinicalMedicine. 2024. PMID: 38638400 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources